(Q44602555)

4 December 2017

title

Use of bisoprolol in heart failure. The BISOCOR observational study (English)

1 reference

reason for deprecated rank

4 December 2017

Empleo de bisoprolol en la insuficiencia cardíaca. Resultados del estudio BISOCOR (Spanish)

marking inconsistent with the registered/official identifier/name

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(03)76975-9

16 March 2024

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(03)76975-9

16 March 2024

author name string

Eduardo Alegría Ezquerra

2

1 reference

4 December 2017

Vicente García Saavedra

3

1 reference

4 December 2017

Germán Pérez Ojeda

4

1 reference

4 December 2017

Manuel Anguita Sánchez

7

1 reference

4 December 2017

Investigadores del Estudio BISCOR

8

1 reference

4 December 2017

José R. González-Juanatey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519274

16 March 2024

José A. Ruiz Ros

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519274

16 March 2024

J. Salvador Espinosa Caliani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519274

16 March 2024

language of work or name

Spanish

0 references

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0300893203769759?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(03)76975-9

https://api.elsevier.com/content/article/PII:S0300893203769759?httpAccept=text/plain

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0300-8932(03)76975-9

Revista Española de Cardiología

16 March 2024

published in

1 reference

4 December 2017

volume

56

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

873-879

1 reference

Overview of the results of recent beta blocker trials

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Beta-blockers: new standard therapy for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Benefits of beta-blocker therapy for heart failure: weighing the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Bisoprolol in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Baseline predictors of tolerability to carvedilol in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976975-9

7 January 2021

Identifiers

1 reference

4 December 2017

1 reference